Physical activity could help colon cancer survivors match general population survival rates

Physical activity may help colon cancer survivors achieve long-term survival rates similar to those of people in the general population, according to a recent study published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.

Individuals with colon cancer face higher rates of premature mortality than people in the general population with matched characteristics such as age and sex. To assess whether exercise might reduce this disparity, investigators analyzed data from two posttreatment trials in patients with stage 3 colon cancer, with a total of 2,875 patients who self-reported physical activity after cancer surgery and chemotherapy. The researchers also examined data on a matched general population from the National Center for Health Statistics. For all participants, physical activity was based on metabolic equivalent (MET) hours per week. (Health guidelines recommend 150 minutes of moderate-intensity exercise per week, translating to approximately 8 MET-hours/week.)

In the analysis of data from the first trial (called CALGB 89803), for patients who were alive at three years after cancer treatment, those with <3.0 MET-hours/week had subsequent 3-year overall survival rates that were 17.1% lower than the matched general population, but those with ≥18.0 MET-hours/week had only 3.5% lower subsequent 3-year overall survival rates than the matched general population. In the second trial (CALGB 80702), among patients who were alive at three years, those with <3.0 and ≥18.0 MET-hours/week had subsequent 3-year overall survival rates that were 10.8% and 4.4% lower than the matched general population, respectively.

In pooled analyses of the two trials, among the 1,908 patients who were alive and did not have cancer recurrence by year three, those with <3.0 and ≥18.0 MET-hours/week had subsequent 3-year overall survival rates that were 3.1% lower and 2.9% higher than the matched general population, respectively. Therefore, cancer survivors who were tumor-free by year three and regularly exercised achieved even better subsequent survival rates than those seen in the matched general population.

This new information can help patients with colon cancer understand how factors that they can control-their physical activity levels-can have a meaningful impact on their long-term prognosis. Also, medical and public health personnel and policymakers are always seeking new ways to communicate the benefits of a healthy lifestyle. Quantifying how physical activity may enable a patient with colon cancer to have a survival experience that approximates their friends and family without cancer could be a simple but powerful piece of information that can be leveraged to help everyone understand the health benefits of physical activity."

Justin C. Brown, PhD, lead author of the Pennington Biomedical Research Center and the Louisiana State University Health Sciences Center

Source:
Journal reference:

Brown, J. C., et al. (2025) The association of physical activity with survival in colon cancer versus a matched general population: Data from Cancer and Leukemia Group B 89803 and 80702 (Alliance). CANCER. doi.org/10.1002/cncr.35727.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New mRNA technique targets disease cells while sparing healthy ones